Allogene Therapeutics, Inc. (ALLO)

1.58 -0.05 (-3.07%) USD  |  NASDAQ  |  Jan 20, 15:54
More

Allogene Therapeutics EV to Free Cash Flow

EV to Free Cash Flow Chart

View EV to Free Cash Flow for ALLO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Free Cash Flow Range, Past 5 Years

View EV to Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Free Cash Flow Benchmarks

View EV to Free Cash Flow Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade

EV to Free Cash Flow Related Metrics

EV to CFO Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade